Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea

Journal of Medical Virology

Volumn 78, Issue 12, 2006, Pages 1564-1571

  Ahn, Sang Hoon ^a   Kim, Do Young ^a   Chang, Hye Young ^a   Hong, Sun Pyo ^b   Shin, Jeon Soo ^a   Kim, Yu Seun ^a   Kim, Hyejin ^a   Kim, Ja Kyung ^a   Paik, Yong Han ^a   Lee, Kwan Sik ^a   Chon, Chae Yoon ^a   Moon, Young Myoung ^a   Han, Kwang Hyub ^a  

^a Yonsei University College of Medicine   (South Korea)

^b GeneMatrix Inc   (South Korea)

Author keywords

CCR5; Genetic polymorphism; Hepatitis B virus; RANTES

Indexed keywords

CHEMOKINE RECEPTOR CCR5; LIGAND; RANTES;

ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; SOUTH KOREA; VIRUS REPLICATION;

ADULT; CARRIER STATE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; KOREA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RANTES; RECEPTORS, CCR5; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VARIATION (GENETICS);

HEPATITIS B VIRUS;

EID: 33750571393     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20739     Document Type: Article

References (36)

1. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon YM. 2000. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatotology 31:1371-1373.
2. Algood HM, Flynn JL. 2004. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 173:3287-3296.
3. Almarri A, Batchelor JR. 1994. HLA and hepatitis B infection. Lancet 344:1194-1195.
4. Berger EA, Murphy PM, Farber JM. 1999. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism and disease. Annu Rev Immunol 17:657-700.
5. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, Penna A, Fiaccadori F, Del Prete G, Ferrari C. 1997. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112:193-199.
6. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134.
7. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
8. Clegg AO, Ashton LJ, Biti RA, Badhwar P, Williamson P, Kaldor JM, Stewart GJ. 2000. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group. AIDS 14:103-108.
9. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. 1995. Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis. Dig Dis Sci 40:2098-2106.
10. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N. 2000. Contrasting effect of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156:1951-1959.
11. Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, Knapp S, Ramaley P, Satsangi J, Wright M, Zhang L, Thomas HC, Thursz M, Hill AV. 2003. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 38:1468-1476.
12. Hong SP, Kim NK, Hwang SG, Chung HJ, Kim S, Han JH, Kim HT, Rim KS, Kang MS, Yoo W, Kim SO. 2004. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. J Hepatol 40:837-844.
13. Kim HS, Han KH, Ahn SH, Kim EO, Chang HY, Moon MS, Chung HJ, Yoo W, Kim SO, Hong SP. 2005. Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization. Antivir Ther 10:441-449.
14. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337:1733-1745.
15. Liu R, Zhao X, Gurney TA, Landau NR. 1998. Functional analysis of the proximal CCR5 promoter. AIDS Res Hum Retroviruses 14:1509-1519.
16. Luster AD. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445.
17. Magierowska M, Lepage V, Boubnova L, Carcass: C, de Juan D, Djoulah S, El Chenawi F, Grunnet N, Halle L, Ivanova R, Jungerman M, Naumova E, Petrany G, Sonnerborg A, Stavropoulos C, Thorsby E, Vu-Trieu A, Debre P, Theodorou I, Charron D. 1998. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3′A variant in healthy individuals from different populations. Immunogenetics 48:417-419.
18. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM. 1998. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352:866-870.
19. Michael NL, Louie LG., Rohrbaugh AL, Schultz KA, Dayhoff DE, Wang CE, Sheppard HW. 1997. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 3:1160-1162.
20. Moreno C, Gustot T, Nicaise C, Quertinmont E, Nagy N, Parmentier M, Le Moine O, Deviere J, Louis H. 2005. CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology 42:854-862.
21. Moriuchi H, Moriuchi M, Fauci AS. 1997. Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J Immunol 159:5441-5449.
22. Mueller A, Strange PG. 2004. The chemokine receptor, CCR5. Int J Biochem Cell Biol 36:35-38.
23. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Stephan KT, Craig FE, O'Connell P, Tryon V, Clark RA, Dolan MJ, Ahuja SK. 1998. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 4:786-793.
24. Murai M, Yoneyama H, Harada A, Yi Z, Vestergaard C, Guo B, Suzuki K, Asakura H, Matsushima K. 1999. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 104:49-57.
25. Paxton WA, Liu R, Kang S, Wu L, Gingeras TR, Landau NR, Mackay CR, Koup RA. 1998. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of beta-chemokines. Virology 244:66-73.
26. Penna A, Del Prete G, Cavalli A, Bertoletti A, D'Elios MM, Sorrentino R, D'Amato M, Boni C, Pilli M, Fiaccadori F, Ferrari C. 1997. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 25:1022-1027.
27. Promrat K, Mcdermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ. 2003. Association of chemokine system polymorphism with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124:352-360.
28. Rehermann B. 2003. Immune responses in hepatitis B virus infection. Semin Liver Dis 23:21-38.
29. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. 1999. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunnol 163:6236-6243.
30. Thelen M. 2001. Dancing to the tune of chemokines. Nat Immunol 2:129-134.
31. Thio CL, Carrington M, Marti D, O'Brien SJ, Vtahov D, Nelson KE, Astemborski J, Thomas DL. 1999. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis 179:1004-1006.
32. Thio CL, Thomas DL, Carrington M. 2000. Chronic viral hepatitis and the human genome. Hepatotolgy 31:819-827.
33. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. 1995. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 332:1065-1069.
34. Welniak LA, Wang Z, Sun K, Kuziel W, Anver MR, Blazar BR, Murphy WJ. 2004. An absence of CCR5 on donor cells results in acceleration of acute graft versus-host disease. Exp Hematol 32:318-324.
35. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, Mackay CR. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 185:1681-1691.
36. Zavaglia C, Bortolon C, Ferrioli G, Rho A, Mondazzi L, Bottelli R, Ghessi A, Gelosa F, Iamoni G, Ideo G. 1996. HLA typing in chronic type B, D and C hepatitis. J Hepatol 24:658-665.